Breaking News

Kaneka Eurogentec to Build Biologics Mfg. Facility

Will allow GMP production of kg scale plasmid DNA and recombinant protein intended for clinical phases and commercialization

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kaneka Eurogentec, a custom service and FDA inspected contract development and manufacturing organization (CDMO), unveiled plans to build a new state of-the-art GMP facility adjacent to its current facility and equipped with a 2200 L fermenter. The expansion will allow for the large-scale production of biopharmaceuticals including recombinant proteins, antibody fragments and plasmid DNA.   The multi-product facility will include the capability for large-scale production using innovative Euroge...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters